3′,4′-Dihydroxyflavonol Modulates the Cell Cycle in Cancer Cells: Implication as a Potential Combination Drug in Osteosarcoma

New agents are demanded to increase the therapeutic options for osteosarcoma (OS). Although OS is the most common bone cancer in children and adolescents, it is considered a rare disorder. Therefore, finding adjuvant drugs has potential to advance therapy for this disease. In this study, 3′,4′-dihyd...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira de Oliveira, José Miguel P., Almeida, Joana Filipa D., Martins, Maria, Proença, Carina, Oliveira, Helena, Fernandes, Eduarda, Santos, Conceição
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308859/
https://www.ncbi.nlm.nih.gov/pubmed/34358066
http://dx.doi.org/10.3390/ph14070640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308859/
https://www.ncbi.nlm.nih.gov/pubmed/34358066
http://dx.doi.org/10.3390/ph14070640

Ejemplares similares